Average Co-Inventor Count = 3.63
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Dana-farber-cancer Institute Inc. (27 from 1,209 patents)
2. Children's Medical Center Corporation (2 from 1,036 patents)
27 patents:
1. 12023385 - Tunable endogenous protein degradation with heterobifunctional compounds
2. 11944625 - Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies
3. 11583586 - Methods to induce targeted protein degradation through bifunctional molecules
4. 11578075 - Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
5. 11311609 - Regulating chimeric antigen receptors
6. 11306105 - Cyano thienotriazolodiazepines and uses thereof
7. 11293023 - Tunable endogenous protein degradation
8. 11285218 - Degradation of bromodomain-containing protein 9 (BRD9) by conjugation of BRD9 inhibitors with E3 ligase ligand and methods of use
9. 11059801 - Methods to induce targeted protein degradation through bifunctional molecules
10. 11046954 - Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses
11. 10980808 - Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies
12. 10925868 - Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
13. 10899768 - Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
14. 10849980 - Methods to induce targeted protein degradation through bifunctional molecules
15. 10793571 - Uses of diazepane derivatives